The average analysts' target price is $7.00 for Genocea Biosciences using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Genocea Biosciences is ranked 19.
|Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Genocea Biosciences is ranked 448.
|Up EPS Surprise
Genocea Biosciences beat the consensus earnings estimate when it last reported quarterly earnings.
Genocea Biosciences rank is 112
Genocea Biosciences rank is 322
Genocea Biosciences rank is 1145
Genocea Biosciences rank is 1471